Reply to Chang and Yew
Am J Respir Crit Care Med
.
2020 Sep 1;202(5):778-779.
doi: 10.1164/rccm.202003-0698LE.
Authors
Giovanni Sotgiu
1
,
Giovanni Battista Migliori
2
,
Dick Menzies
3
,
Sundari Mase
4
,
Terence Chorba
5
,
Barbara Seaworth
6
,
Payam Nahid
7
Affiliations
1
University of Sassari Sassari, Italy.
2
Istituti Clinici Scientifici Maugeri-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Tradate, Italy.
3
Research Institute of the McGill University Health Centre Montreal, Québec, Canada.
4
Independent Consultant San Francisco, California.
5
Centers for Disease Control and Prevention Atlanta, Georgia.
6
University of Texas Health Science Center Tyler, Texas and.
7
University of California San Francisco San Francisco, California.
PMID:
32374628
PMCID:
PMC7462397
DOI:
10.1164/rccm.202003-0698LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Centers for Disease Control and Prevention, U.S.
Humans
Tuberculosis, Multidrug-Resistant*
United States